Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer.
Zaid TM, Yeung TL, Thompson MS, Leung CS, Harding T, Co NN, Schmandt RS, Kwan SY, Rodriguez-Aguay C, Lopez-Berestein G, Sood AK, Wong KK, Birrer MJ, Mok SC.
Zaid TM, et al. Among authors: yeung tl.
Clin Cancer Res. 2013 Feb 15;19(4):809-20. doi: 10.1158/1078-0432.CCR-12-2736. Epub 2013 Jan 23.
Clin Cancer Res. 2013.
PMID: 23344261
Free PMC article.